Jeffrey J. Scherman - 09 May 2025 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Role
Chief Accounting Officer
Signature
/s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact
Issuer symbol
NEUE
Transactions as of
09 May 2025
Net transactions value
$0
Form type
4
Filing time
13 May 2025, 18:06:42 UTC
Previous filing
17 Mar 2025
Next filing
14 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Scherman Jeffrey J Chief Accounting Officer C/O NEUEHEALTH, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS /s/ Eric Halverson for Jeffrey J. Scherman, Attorney-in-Fact 13 May 2025 0001867147

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +341 +2.8% 12,575 09 May 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -341 -100% $0.000000 0 09 May 2025 Common Stock 341 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These restricted stock units vested over three years as follows: (a) one-third of the original grant amount vested on May 9, 2023, (b) one-third of the original grant amount vested on May 9, 2024, (c) and one-third of the original grant amount vested on May 9, 2025.